March 18 (Reuters) - ADC Therapeutics SA :
* Q4 DILUTED LOSS PER SHARE 0.73 USD VERSUS 0.69 USD LOSS YEAR AGO
* QTRLY NET LOSS PER SHARE, BASIC AND DILUTED $0.73
* QTRLY ADJUSTED NET LOSS PER SHARE, BASIC AND DILUTED $0.82
Source text for Eikon: Further company coverage:
((Reuters.Briefs@thomsonreuters.com;)
* Q4 DILUTED LOSS PER SHARE 0.73 USD VERSUS 0.69 USD LOSS YEAR AGO
* QTRLY NET LOSS PER SHARE, BASIC AND DILUTED $0.73
* QTRLY ADJUSTED NET LOSS PER SHARE, BASIC AND DILUTED $0.82
Source text for Eikon: Further company coverage:
((Reuters.Briefs@thomsonreuters.com;)